WuXi Biologics (Cayman) Inc (WXXWY)
3.312
-0.02
(-0.69%)
USD |
OTCM |
May 22, 16:00
WuXi Biologics Cash from Investing (TTM): -454.47M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -454.47M |
June 30, 2023 | -725.15M |
December 31, 2022 | -855.84M |
June 30, 2022 | -648.12M |
December 31, 2021 | -1.489B |
June 30, 2021 | -1.679B |
December 31, 2020 | -1.049B |
June 30, 2020 | -1.001B |
Date | Value |
---|---|
December 31, 2019 | -644.66M |
June 30, 2019 | -349.46M |
December 31, 2018 | -53.56M |
June 30, 2018 | -221.32M |
December 31, 2017 | -333.59M |
June 30, 2017 | -68.61M |
December 31, 2016 | -62.24M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-1.679B
Minimum
Jun 2021
-349.46M
Maximum
Jun 2019
-889.49M
Average
-790.49M
Median
Cash from Investing (TTM) Benchmarks
Wuxi AppTec Co Ltd | -1.010B |
Sinovac Biotech Ltd | -- |
CASI Pharmaceuticals Inc | -- |
Zai Lab Ltd | 46.47M |
Gracell Biotechnologies Inc (DELISTED) | -- |